07.01.2013 Views

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

GRP<br />

8771<br />

CCP<br />

84182<br />

derived from vegetables such as brussel sprouts. Significant contact with cyanide can produce blood<br />

concentrations up to 2.0 mcg/mL without side effects. At concentrations of 2.0 mcg/mL to 4.0 mcg/mL,<br />

giddiness, headaches, and hyperpnea are evident. Concentrations >5.0 mcg/mL are potentially lethal.<br />

Normal concentration: or =2.0 mcg/mL<br />

Reference Values:<br />

Normal: or =2.0 mcg/mL<br />

Clinical References: <strong>Medical</strong> Toxicology, 3rd edition, RC Dart editor. 2004 pp 1162, 1800<br />

Cyclic AMP, Urinary Excretion<br />

Clinical Information: Cyclic AMP functions as an intracellular "second messenger" regulating the<br />

activity of intracellular enzymes or proteins in response to a variety of hormones (eg, parathyroid<br />

hormone). Urinary cyclic AMP is elevated in about 85% of patients with hyperparathyroidism.<br />

Useful For: The differential diagnosis of hypercalcemia An adjunct to serum parathyroid hormone<br />

measurements, especially in the diagnosis of parathyroid hormone resistance states, such as<br />

pseudohypoparathyroidism<br />

Interpretation: Urinary cyclic AMP is elevated in about 85% of patients with hyperparathyroidism<br />

and in about 50% of patients with humoral hypercalcemia of malignancy.<br />

Reference Values:<br />

1.3-3.7 nmol/dL of glomerular filtrate<br />

Clinical References: Aurbach GD, Marx SJ, Spiegel AM: Parathyroid hormone, calcitonin, and the<br />

calciferols. In Williams Textbook of Endocrinology. Eighth edition. Edited by JD Wilson, DW Foster.<br />

Philadelphia, WB Saunders Company, 1992, pp 1413-1415<br />

Cyclic Citrullinated Peptide Antibodies, IgG, Serum<br />

Clinical Information: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by<br />

chronic joint inflammation that ultimately leads to joint destruction. RA affects approximately 1% of the<br />

world's population. The diagnosis of RA is established primarily on clinical criteria and serologic<br />

findings. Historically, rheumatoid factor (RF), which is an antibody specific for the Fc portion of human<br />

IgG, has been considered a marker for RA. RF is, in fact, one of the diagnostic criteria for RA that was<br />

established by the American College of Rheumatology (1). Although 50% to 90% of patients with RA are<br />

RF-positive, the specificity of the RF test is known to be relatively poor. RF is found in many patients<br />

with other autoimmune diseases, infectious diseases and some healthy individuals. Consequently, a search<br />

for better diagnostic markers, with improved specificity for RA, ensued. Antiperinuclear factor (APF) and<br />

antikeratin antibodies (AKA), identified by immunofluorescence, were found to have a specificity of close<br />

to 90% for RA, but testing for these autoantibodies has never become popular. It was subsequently<br />

determined that APF and AKA react with the same antigen, specifically a citrullinated form of filaggrin<br />

(citrulline is an unusual amino acid formed by posttranslational modification of arginine residues by the<br />

enzyme peptidyl arginine deaminase) (2). Recombinant filaggrin fragments, after enzymatic deamination<br />

in vitro, react with autoantibodies in RA sera. Synthetic cyclic citrullinated peptide (CCP) variants also<br />

react with anti-filaggrin autoantibodies and serve as the substrate for detecting anti-CCP antibodies<br />

serologically. Most studies of anti-CCP antibodies demonstrated that these autoantibodies have much<br />

improved specificity for RA compared to RF (3). See Connective Tissue Diseases Cascade <strong>Test</strong>-Ordering<br />

Algorithm in Special Instructions, also see Optimized Laboratory <strong>Test</strong>ing for Connective Tissue Diseases<br />

in Primary Care: The <strong>Mayo</strong> Connective Tissue Diseases Cascade in Publications.<br />

Useful For: Evaluating patients suspected of having rheumatoid arthritis (RA) Differentiating RA from<br />

other connective tissue diseases that may present with arthritis<br />

Interpretation: A positive result for cyclic citrullinated peptide (CCP) antibodies indicates a high<br />

Current as of January 3, 2013 2:22 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong>Laboratories.com Page 568

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!